Cytokinetics, Incorporated (CYTK)
NASDAQ·Healthcare·Biotechnology
$53.80
+0.34%
Mkt Cap $7.46B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (56 analysts)
$112.50
Range $95.00 – $140.00
Implied Upside
+109.1%
Consensus $112.50 vs current $53.80
NASDAQ·Healthcare·Biotechnology
$53.80
+0.34%
Mkt Cap $7.46B
Buy
14
Hold
0
Sell
0
Price Target (56 analysts)
$112.50
Range $95.00 – $140.00
+109.1%
Consensus $112.50 vs current $53.80